204 related articles for article (PubMed ID: 11520816)
41. Allelic exclusion at the TCR delta locus and commitment to gamma delta lineage: different modalities apply to distinct human gamma delta subsets.
Couedel C; Lippert E; Bernardeau K; Bonneville M; Davodeau F
J Immunol; 2004 May; 172(9):5544-52. PubMed ID: 15100297
[TBL] [Abstract][Full Text] [Related]
42. Gammadelta T cells for immune therapy of patients with lymphoid malignancies.
Wilhelm M; Kunzmann V; Eckstein S; Reimer P; Weissinger F; Ruediger T; Tony HP
Blood; 2003 Jul; 102(1):200-6. PubMed ID: 12623838
[TBL] [Abstract][Full Text] [Related]
43. Peripheral selection of antigen receptor junctional features in a major human gamma delta subset.
Davodeau F; Peyrat MA; Hallet MM; Houde I; Vie H; Bonneville M
Eur J Immunol; 1993 Apr; 23(4):804-8. PubMed ID: 8384559
[TBL] [Abstract][Full Text] [Related]
44. Nonpeptide antigens, presentation mechanisms, and immunological memory of human Vgamma2Vdelta2 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens.
Morita CT; Jin C; Sarikonda G; Wang H
Immunol Rev; 2007 Feb; 215():59-76. PubMed ID: 17291279
[TBL] [Abstract][Full Text] [Related]
45. Risedronate: a new oral bisphosphonate.
Umland EM; Boyce EG
Clin Ther; 2001 Sep; 23(9):1409-21. PubMed ID: 11589256
[TBL] [Abstract][Full Text] [Related]
46. Aminobisphosphonates Synergize with Human Cytomegalovirus To Activate the Antiviral Activity of Vγ9Vδ2 Cells.
Daguzan C; Moulin M; Kulyk-Barbier H; Davrinche C; Peyrottes S; Champagne E
J Immunol; 2016 Mar; 196(5):2219-29. PubMed ID: 26819204
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis.
Halasy-Nagy JM; Rodan GA; Reszka AA
Bone; 2001 Dec; 29(6):553-9. PubMed ID: 11728926
[TBL] [Abstract][Full Text] [Related]
48. Distinct tumour specificity and IL-7 requirements of CD56(-)and CD56(+) subsets of human gamma delta T cells.
Zheng B; Lam C; Im S; Huang J; Luk W; Lau SY; Yau KK; Wong C; Yao K; Ng MH
Scand J Immunol; 2001 Jan; 53(1):40-8. PubMed ID: 11169205
[TBL] [Abstract][Full Text] [Related]
49. Bisphosphonates: new indications and methods of administration.
Reid IR
Curr Opin Rheumatol; 2003 Jul; 15(4):458-63. PubMed ID: 12819475
[TBL] [Abstract][Full Text] [Related]
50. Treatment of osteoporosis with bisphosphonates.
Watts NB
Rheum Dis Clin North Am; 2001 Feb; 27(1):197-214. PubMed ID: 11285996
[TBL] [Abstract][Full Text] [Related]
51. Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial origin.
Maeurer MJ; Martin D; Walter W; Liu K; Zitvogel L; Halusczcak K; Rabinowich H; Duquesnoy R; Storkus W; Lotze MT
J Exp Med; 1996 Apr; 183(4):1681-96. PubMed ID: 8666926
[TBL] [Abstract][Full Text] [Related]
52. Oral bisphosphonates: A review of clinical use in patients with bone metastases.
Major PP; Lipton A; Berenson J; Hortobagyi G
Cancer; 2000 Jan; 88(1):6-14. PubMed ID: 10618600
[TBL] [Abstract][Full Text] [Related]
53. Modulation of TNF-alpha gene expression by IFN-gamma and pamidronate in murine macrophages: regulation by STAT1-dependent pathways.
Takagi K; Takagi M; Kanangat S; Warrington KJ; Shigemitsu H; Postlethwaite AE
J Immunol; 2005 Feb; 174(4):1801-10. PubMed ID: 15699106
[TBL] [Abstract][Full Text] [Related]
54. Preferential recognition of a microbial metabolite by human Vgamma2Vdelta2 T cells.
Puan KJ; Jin C; Wang H; Sarikonda G; Raker AM; Lee HK; Samuelson MI; Märker-Hermann E; Pasa-Tolic L; Nieves E; Giner JL; Kuzuyama T; Morita CT
Int Immunol; 2007 May; 19(5):657-73. PubMed ID: 17446209
[TBL] [Abstract][Full Text] [Related]
55. Molecular and cellular analysis of human T lymphocytes expressing gamma delta T-cell receptor.
Moretta L; Ciccone E; Ferrini S; Pelicci PG; Mingari MC; Zeromski J; Bottino C; Grossi C; Moretta A
Immunol Rev; 1991 Apr; 120():117-35. PubMed ID: 1650757
[TBL] [Abstract][Full Text] [Related]
56. DC-like cell-dependent activation of human natural killer cells by the bisphosphonate zoledronic acid is regulated by γδ T lymphocytes.
Nussbaumer O; Gruenbacher G; Gander H; Thurnher M
Blood; 2011 Sep; 118(10):2743-51. PubMed ID: 21673342
[TBL] [Abstract][Full Text] [Related]
57. Most IL-4-producing gamma delta thymocytes of adult mice originate from fetal precursors.
Grigoriadou K; Boucontet L; Pereira P
J Immunol; 2003 Sep; 171(5):2413-20. PubMed ID: 12928388
[TBL] [Abstract][Full Text] [Related]
58. MICA expressed by multiple myeloma and monoclonal gammopathy of undetermined significance plasma cells Costimulates pamidronate-activated gammadelta lymphocytes.
Girlanda S; Fortis C; Belloni D; Ferrero E; Ticozzi P; Sciorati C; Tresoldi M; Vicari A; Spies T; Groh V; Caligaris-Cappio F; Ferrarini M
Cancer Res; 2005 Aug; 65(16):7502-8. PubMed ID: 16103105
[TBL] [Abstract][Full Text] [Related]
59. Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro.
Idris AI; Rojas J; Greig IR; Van't Hof RJ; Ralston SH
Calcif Tissue Int; 2008 Mar; 82(3):191-201. PubMed ID: 18259679
[TBL] [Abstract][Full Text] [Related]
60. Binding and antiresorptive properties of heterocycle-containing bisphosphonate analogs: structure-activity relationships.
van Beek ER; Löwik CW; Ebetino FH; Papapoulos SE
Bone; 1998 Nov; 23(5):437-42. PubMed ID: 9823450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
